This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
When these two medicines are taken together, your body may not process disopyramide properly.
What might happen:
You may experience an increase in the toxic effects and a decrease in the beneficial effects of disopyramide.
What you should do about this interaction:
Contact your doctor if you experience dry mouth, blurred vision, or decreased sweating.If your doctor prescribes these medicines together, it may be necessary to adjust your dose of disopyramide and measure your blood levels more often.Your healthcare professionals (e.g. doctor or pharmacist) may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Aitio ML, Vuorenmaa T. Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?. Br J Clin Pharmacol 1980 Feb; 9(2):149-52.
2.Aitio ML, Mansury L, Tala E, Haataja M, Aitio A. The effect of enzyme induction on the metabolism of disopyramide in man. Br J Clin Pharmacol 1981 Mar;11(3):279-85.
3.Aitio ML. Plasma concentrations and protein binding of disopyramide and mono-N- dealkyldisopyramide during chronic oral disopyramide therapy. Br J Clin Pharmacol 1981 Apr;11(4):369-75.
4.Matos JA, Fisher JD, Kim SG. Disopyramide - phenytoin interaction. Clin Res 1981;29(3):655A.
5.Kessler JM, Keys PW, Stafford RW. Disopyramide and phenytoin interaction. Clin Pharm 1982 May-Jun;1(3):263-4.
6.Nightingale J, Nappi JM. Effect of phenytoin on serum disopyramide concentrations. Clin Pharm 1987 Jan;6(1):46-50.